GovIntel / AL / Diamond Therapeutics USA Inc.

Diamond Therapeutics USA Inc.

Government contractor · Birmingham, AL

UEIURYRAYBLNGA5
CAGE1ALS1
SAM statusActive
Established2024

About Diamond Therapeutics USA Inc.

Diamond Therapeutics Inc. is a company focused on developing FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions using psychedelic compounds, particularly sub-perceptual psilocybin-based medicines. The company aims to provide more effective, safer, and faster-acting treatments for mental health disorders.

Development of FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditionsResearch and development of sub-perceptual psilocybin-based medicinesAdvancement of tryptamine analogs and small organic molecules that modulate serotonin receptors and neurotrophic signalingClinical program focused on rapid therapeutic outcomes without perceptual side effects

Is this your company?

Claim Diamond Therapeutics USA Inc. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim Diamond Therapeutics USA Inc. & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.